Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

One-year results of three monthly ranibizumab injections and as-needed reinjections for polypoidal choroidal vasculopathy in Japanese patients.

Hikichi T, Higuchi M, Matsushita T, Kosaka S, Matsushita R, Takami K, Ohtsuka H, Ariga H.

Am J Ophthalmol. 2012 Jul;154(1):117-124.e1. doi: 10.1016/j.ajo.2011.12.019. Epub 2012 Apr 1.

PMID:
22465366
[PubMed - indexed for MEDLINE]
2.

EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.

Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, Lai TY, Pilz S, Ruamviboonsuk P, Tokaji E, Weisberger A, Lim TH.

Retina. 2012 Sep;32(8):1453-64.

PMID:
22426346
[PubMed - indexed for MEDLINE]
3.

Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathy.

Cho HJ, Kim JW, Lee DW, Cho SW, Kim CG.

Eye (Lond). 2012 Mar;26(3):426-33. doi: 10.1038/eye.2011.324. Epub 2011 Dec 16.

PMID:
22173075
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.

Saito M, Iida T, Kano M.

Am J Ophthalmol. 2012 Mar;153(3):504-514.e1. doi: 10.1016/j.ajo.2011.08.038. Epub 2011 Nov 10.

PMID:
22078902
[PubMed - indexed for MEDLINE]
5.

Early responses to intravitreal ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Matsumiya W, Honda S, Bessho H, Kusuhara S, Tsukahara Y, Negi A.

J Ophthalmol. 2011;2011:742020. doi: 10.1155/2011/742020. Epub 2011 Jun 12.

PMID:
21772985
[PubMed]
Free PMC Article
6.

One-year results of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy.

Song MH, Ryu HW, Roh YJ.

Ophthalmologica. 2011;226(3):119-26. doi: 10.1159/000329466. Epub 2011 Jul 13.

PMID:
21757883
[PubMed - indexed for MEDLINE]
7.

Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.

Wakabayashi T, Gomi F, Sawa M, Tsujikawa M, Nishida K.

Br J Ophthalmol. 2012 Mar;96(3):394-9. doi: 10.1136/bjo.2011.204123. Epub 2011 Jun 30.

PMID:
21719568
[PubMed - indexed for MEDLINE]
8.

Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathy.

Kim KS, Lee WK.

Jpn J Ophthalmol. 2011 Jul;55(4):370-7. doi: 10.1007/s10384-011-0045-z. Epub 2011 Jun 7.

PMID:
21647565
[PubMed - indexed for MEDLINE]
9.

Ranibizumab in retinal angiomatous proliferation (RAP): influence of RAP stage on visual outcome.

Reche-Frutos J, Calvo-Gonzalez C, PĂ©rez-Trigo S, Fernandez-Perez C, Donate-Lopez J, Garcia-Feijoo J.

Eur J Ophthalmol. 2011 Nov-Dec;21(6):783-8. doi: 10.5301/EJO.2011.6526.

PMID:
21484755
[PubMed - indexed for MEDLINE]
10.

Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study.

Holz FG, Amoaku W, Donate J, Guymer RH, Kellner U, Schlingemann RO, Weichselberger A, Staurenghi G; SUSTAIN Study Group.

Ophthalmology. 2011 Apr;118(4):663-71. doi: 10.1016/j.ophtha.2010.12.019.

PMID:
21459217
[PubMed - indexed for MEDLINE]
11.

Combination therapy of ranibizumab and photodynamic therapy for retinal angiomatous proliferation with serous pigment epithelial detachment in Korean patients: twelve-month results.

Lee MY, Kim KS, Lee WK.

Retina. 2011 Jan;31(1):65-73. doi: 10.1097/IAE.0b013e3181e586e3.

PMID:
21187732
[PubMed - indexed for MEDLINE]
12.

Inject and extend dosing versus dosing as needed: a comparative retrospective study of ranibizumab in exudative age-related macular degeneration.

Oubraham H, Cohen SY, Samimi S, Marotte D, Bouzaher I, Bonicel P, Fajnkuchen F, Tadayoni R.

Retina. 2011 Jan;31(1):26-30. doi: 10.1097/IAE.0b013e3181de5609.

PMID:
20890246
[PubMed - indexed for MEDLINE]
13.

Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab.

Tsujikawa A, Ooto S, Yamashiro K, Tamura H, Otani A, Yoshimura N.

Jpn J Ophthalmol. 2010 Jul;54(4):310-9. doi: 10.1007/s10384-010-0813-1. Epub 2010 Aug 11.

PMID:
20700799
[PubMed - indexed for MEDLINE]
14.

A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact.

Gupta OP, Shienbaum G, Patel AH, Fecarotta C, Kaiser RS, Regillo CD.

Ophthalmology. 2010 Nov;117(11):2134-40. doi: 10.1016/j.ophtha.2010.02.032. Epub 2010 Jul 1.

PMID:
20591490
[PubMed - indexed for MEDLINE]
15.

Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients.

Suzuki M, Gomi F, Sawa M, Tsujikawa M, Sakaguchi H.

Jpn J Ophthalmol. 2010 Mar;54(2):124-8. doi: 10.1007/s10384-009-0775-3. Epub 2010 Apr 18.

PMID:
20401560
[PubMed - indexed for MEDLINE]
16.

EXTEND-I: safety and efficacy of ranibizumab in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Tano Y, Ohji M; EXTEND-I Study Group.

Acta Ophthalmol. 2010 May;88(3):309-16. doi: 10.1111/j.1755-3768.2009.01843.x. Epub 2010 Feb 16.

PMID:
20163368
[PubMed - indexed for MEDLINE]
17.

A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.

Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W, Davis JL, Flynn HW Jr, Esquiabro M.

Am J Ophthalmol. 2009 Jul;148(1):43-58.e1. doi: 10.1016/j.ajo.2009.01.024. Epub 2009 Apr 18.

PMID:
19376495
[PubMed - indexed for MEDLINE]
18.

Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.

Regillo CD, Brown DM, Abraham P, Yue H, Ianchulev T, Schneider S, Shams N.

Am J Ophthalmol. 2008 Feb;145(2):239-248. doi: 10.1016/j.ajo.2007.10.004.

PMID:
18222192
[PubMed - indexed for MEDLINE]
19.

Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy.

Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Oshima Y, Kamei M, Tano Y.

Br J Ophthalmol. 2008 Jan;92(1):70-3. Epub 2007 Jun 13.

PMID:
17567661
[PubMed - indexed for MEDLINE]
20.

Clinical characteristics of exudative age-related macular degeneration in Japanese patients.

Maruko I, Iida T, Saito M, Nagayama D, Saito K.

Am J Ophthalmol. 2007 Jul;144(1):15-22. Epub 2007 May 23.

PMID:
17509509
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk